Skip to main content

Advertisement

SpringerLink
Log in

The Role of Artificial Intelligence in Understanding and Addressing Disparities in Breast Cancer Outcomes

  • Breast Cancer Disparities (LA Newman, Section Editor)
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

The goal of our paper is to explore the role of AI in understanding health disparities in cancer care and its potential role in resolving them.

Recent Findings

Multiple studies have shown that with the recent advances in AI, its integration in cancer care has the potential to impact earlier diagnosis and improve clinical decision making. While AI risks to further widen health disparities, some studies suggest that it represents an excellent opportunity for resolving them.

Summary

With active engagement, incorporating AI in breast cancer care represents an excellent opportunity for elucidating and resolving health disparities; however, without deliberate effort, it risks to further widen them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Centers for Disease Control and Prevention website. United States cancer statistics 2014. https://www.cdc.gov/cancer/breast/statistics/index. htm. Accessed February 2, 2020.

  2. American Cancer Society website. Breast Cancer Facts&Figures 2017–2018. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/breast-cancer-facts-and-figures/breast-cancer-facts-and-figures-2017-2018.pdf. Accessed Feb 2, 2020.

  3. American Cancer Society. Cancer prevention & early detection facts & figures, 2019–2020. Atlanta: American Cancer Society; 2019.

    Google Scholar 

  4. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, et al. Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin. 2006;56(3):168–83.

    Article  Google Scholar 

  5. Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, et al. Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat. 2012;136(3):813–21.

    Article  Google Scholar 

  6. Foy KC, Fisher JL, Lustberg MB, Gray DM, DeGraffinreid CR, Paskett ED. Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women. NPJ Breast Cancer. 2018;4:7.

    Article  Google Scholar 

  7. American Cancer Society. Cancer facts and figures for Hispanics/Latinos, 2018–2020. Atlanta: American Cancer Society; 2018.

    Google Scholar 

  8. Gordon NP, Rundall TG, Parker L. Type of health care coverage and the likelihood of being screened for cancer. Med Care. 1998;36(5):636–45.

    Article  CAS  Google Scholar 

  9. Hsia J, Kemper E, Kiefe C, Zapka J, Sofaer S, Pettinger M, et al. The importance of health insurance as a determinant of cancer screening: evidence from the Women's Health Initiative. Prev Med. 2000;31(3):261–70.

    Article  CAS  Google Scholar 

  10. Williams F, Thompson E. Disparities in breast cancer stage at diagnosis: importance of race, poverty, and age. J Health Dispar Res Pract. 2017;10(3):34–45.

    PubMed  PubMed Central  Google Scholar 

  11. Dreyer MS, Nattinger AB, McGinley EL, Pezzin LE. Socioeconomic status and breast cancer treatment. Breast Cancer Res Treat. 2018;167(1):1–8.

    Article  Google Scholar 

  12. Inequities and social justice. Breast Cancer Action website. http://www.bcaction.org/our-take-on-breast-cancer/inequities-and-social-justice/. Accessed November 20, 2016.

  13. Lin CC, Bruinooge SS, Kirkwood MK, Olsen C, Jemal A, Bajorin D, et al. Association between geographic access to cancer care, insurance, and receipt of chemotherapy: geographic distribution of oncologists and travel distance. J Clin Oncol. 2015;33(28):3177–85.

    Article  Google Scholar 

  14. Horner-Johnson W, Dobbertin K, Andresen EM, Iezzoni LI. Breast and cervical cancer screening disparities associated with disability severity. Womens Health Issues. 2014;24(1):e147–53.

    Article  Google Scholar 

  15. Centers for Disease Control and Prevention. Women with disabilities and breast cancer screening. http://www.cdc.gov/ncbddd/disabilityandhealth/breast-cancer-screening.html, 2018. Accessed on February 2, 2020.

  16. Access to medical care for individuals with mobility disabilities. https://www.hhs.gov/sites/default/files/ocr/civilrights/understanding/disability/adamobilityimpairmentsgudiance.pdf/. Accessed February 2, 2020.

  17. Castellino RA. Computer aided detection (CAD): an overview. Cancer Imaging. 2005;5:17–9.

    Article  Google Scholar 

  18. Birdwell RL, Ikeda DM, O'Shaughnessy KF, Sickles EA. Mammographic characteristics of 115 missed cancers later detected with screening mammography and the potential utility of computer-aided detection. Radiology. 2001;219(1):192–202.

    Article  CAS  Google Scholar 

  19. McKinney SM, Sieniek M, Godbole V, Godwin J, Antropova N, Ashrafian H, et al. International evaluation of an AI system for breast cancer screening. Nature. 2020;577(7788):89–94.

    Article  CAS  Google Scholar 

  20. Rodriguez-Ruiz A, Lang K, Gubern-Merida A, Broeders M, Gennaro G, Clauser P, et al. Stand-alone artificial intelligence for breast cancer detection in mammography: comparison with 101 radiologists. J Natl Cancer Inst. 2019;111(9):916–22.

    Article  Google Scholar 

  21. •• Pisano ED. AI shows promise for breast cancer screening. Nature. 2020;577(7788):35–6. This article analyzes the accuracy of artificial intelligence in breast cancer screening after the publication of McKinney et al. study inNature. It highlights its potential but also the limitations of AI in detecting breast cancer, suggesting that the clinical implications of the study are yet uncertain.

    Article  CAS  Google Scholar 

  22. •• Bi WL, Hosny A, Schabath MB, Giger ML, Birkbak NJ, Mehrtash A, et al. Artificial intelligence in cancer imaging: clinical challenges and applications. CA Cancer J Clin. 2019;69(2):127–57. This article provides a comprehensive review of AI applications in cancer imaging, biologic characterization of tumors, and its role in assessing response to therapy for a few common cancers, including breast malignancy.

    PubMed  PubMed Central  Google Scholar 

  23. Fujioka T, Kubota K, Mori M, Kikuchi Y, Katsuta L, Kasahara M, et al. Distinction between benign and malignant breast masses at breast ultrasound using deep learning method with convolutional neural network. Jpn J Radiol. 2019;37(6):466–72.

    Article  Google Scholar 

  24. https://koiosmedical.com/solutions/. Accessed February 2 2020.

  25. Pinker K, Shitano F, Sala E, Do RK, Young RJ, Wibmer AG, et al. Background, current role, and potential applications of radiogenomics. J Magn Reson Imaging. 2018;47(3):604–20.

    Article  Google Scholar 

  26. Zhu Y, Li H, Guo W, Drukker K, Lan L, Giger ML, et al. Deciphering genomic underpinnings of quantitative MRI-based radiomic phenotypes of invasive breast carcinoma. Sci Rep. 2015;5:17787.

    Article  CAS  Google Scholar 

  27. von Minckwitz G, Untch M, Blohmer JU, Costa SD, Eidtmann H, Fasching PA, et al. Definition and impact of pathologic complete response on prognosis after neoadjuvant chemotherapy in various intrinsic breast cancer subtypes. J Clin Oncol. 2012;30(15):1796–804.

    Article  Google Scholar 

  28. Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. 2014;384(9938):164–72.

    Article  Google Scholar 

  29. Tran WT, Jerzak K, Lu FI, Klein J, Tabbarah S, Lagree A, et al. Personalized breast cancer treatments using artificial intelligence in radiomics and pathomics. J Med Imaging Radiat Sci. 2019;50(4S2):S32–41.

    Article  Google Scholar 

  30. Esteva A, Kuprel B, Novoa RA, Ko J, Swetter SM, Blau HM, et al. Dermatologist-level classification of skin cancer with deep neural networks. Nature. 2017;542(7639):115–8.

    Article  CAS  Google Scholar 

  31. Schlessinger DI, Chhor G, Gevaert O, Swetter SM, Ko J, Novoa RA. Artificial intelligence and dermatology: opportunities, challenges, and future directions. Semin Cutan Med Surg. 2019;38(1):E31–7.

    Article  Google Scholar 

  32. McCarthy AM, Bristol M, Domchek SM, Groeneveld PW, Kim Y, Motanya UN, et al. Health care segregation, physician recommendation, and racial disparities in BRCA1/2 testing among women with breast cancer. J Clin Oncol. 2016;34(22):2610–8.

    Article  CAS  Google Scholar 

  33. •• Zou J, Schiebinger L. AI can be sexist and racist - it's time to make it fair. Nature. 2018;559(7714):324–6. This commentary article is an excellent review of the sources of bias in AI. It also discusses ways to increase its fairness and objectivity.

    Article  CAS  Google Scholar 

  34. The Dataset Nutrition Label: A framework to drive higher data quality standards Sarah Holland, Ahmed Hosny, Sarah Newman, Joshua Joseph, Kasia Chmielinski Cornell University.

  35. Panch T, Mattie H, Atun R. Artificial intelligence and algorithmic bias: implications for health systems. J Glob Health. 2019;9(2):010318.

    Article  Google Scholar 

  36. Veale M, & Binns R (2017). Fairer machine learning in the real world: mitigating discrimination without collecting sensitive data. Big Data & Society.

  37. Unequal Treatment. Confronting racial and ethnic disparities in health care. In: Smedley BD, Stith AY, Nelson AR, editors. Institute of Medicine (US) Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care. Washington: National Academies Press (US); 2003.

    Google Scholar 

  38. Magrabi F, Ammenwerth E, McNair JB, De Keizer NF, Hypponen H, Nykanen P, et al. Artificial intelligence in clinical decision support: challenges for evaluating AI and practical implications. Yearb Med Inform. 2019;28(1):128–34.

    Article  Google Scholar 

  39. Li J, Cornacchi SD, Farrokhyar F, et al. Relation between socioeconomic variables and surgical, systemic and radiation treatment in a cohort of patients with breast cancer in an urban Canadian centre. Can J Surg. 2019;62(2):83–92. https://doi.org/10.1503/cjs.009217.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Frisell A, Lagergren J, Halle M, de Boniface J. Socioeconomic status differs between breast cancer patients treated with mastectomy and breast conservation, and affects patient-reported preoperative information. Breast Cancer Res Treat. 2020;179(3):721–9.

    Article  CAS  Google Scholar 

  41. IBM Watson for Oncology. https://www.ibm.com/products/clinical-decision-support-oncology. Accessed February 2, 2020.

  42. Jiang Z, Xu F, Martín-J S, Li J, Wang H, Liu Z, et al. Concordance, decision impact and guidelines adherence using artificial intelligence in high-risk breast cancer. J Clin Oncol. 2018;36(15_suppl):e18566.

    Article  Google Scholar 

  43. Confronting the Criticisms Facing Watson for Oncology. https://www.ascopost.com/issues/september-10-2019/confronting-the-criticisms-facing-watson-for-oncology/ Acessed February 2, 2020.

  44. Henley SJ, Anderson RN, Thomas CC, Massetti GM, Peaker B, Richardson LC. Invasive cancer incidence, 2004-2013, and deaths, 2006-2015, in nonmetropolitan and metropolitan counties - United States. MMWR Surveill Summ. 2017;66(14):1–13.

    Article  Google Scholar 

  45. • Wang F, Preininger A. AI in health: state of the art, challenges, and future directions. Yearb Med Inform. 2019;28(1):16–26. This paper discusses the advantages of AI-assisted approaches to healthcare and its challenges, addressing issues such as multimodal data integration, balancing algorithm performance, and model interpretability.

    Article  Google Scholar 

  46. Davenport T, Kalakota R. The potential for artificial intelligence in healthcare. Future Healthc J. 2019;6(2):94–8.

    Article  Google Scholar 

  47. Apple Siri https://www.apple.com/siri/ Accessed February 6th 2020.

  48. Amazon Alexa https://developer.amazon.com/en-US/alexa Accessed February 6th 2020.

  49. Google custom search https://developers.google.com/custom-search/docs/overview Accessed February 6th 2020.

  50. Nelson A, Herron D, Rees G, Nachev P. Predicting scheduled hospital attendance with artificial intelligence. NPJ Digit Med. 2019;2:26.

    Article  Google Scholar 

  51. Predicting missed hospital appointments using machine learning - what are the risks? https://towardsdatascience.com/predicting-missed-hospital-appointments-using-machine-learning-what-are-the-risks-a388348109d Accessed February 6th 2020.

Download references

Author information

Authors and Affiliations

  1. Weill Cornell Medical Center/New York Presbyterian Hospital, 425 East 61st, 9th floor, New York, NY, 10065, USA

    Eralda Mema & Geraldine McGinty

Authors
  1. Eralda Mema
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Geraldine McGinty
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eralda Mema.

Ethics declarations

Conflict of Interest

Eralda Mema and Geraldine McGinty declare no conflict of interest relevant to this manuscript.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Breast Cancer Disparities

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mema, E., McGinty, G. The Role of Artificial Intelligence in Understanding and Addressing Disparities in Breast Cancer Outcomes. Curr Breast Cancer Rep 12, 168–174 (2020). https://doi.org/10.1007/s12609-020-00368-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-020-00368-x

Keywords

Search

Navigation